Indofarma (Persero) Tbk PT operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Indofarma (Persero) Tbk PT with three other
pharmaceutical manufacturers in Asia:
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
sales of 849.33 million Chinese Renmimbi [US$125.51 million]
of which 100%
was Medicine Product),
Anhui Anke Biotechnology (Group) Company., Limited
(849.19 million Chinese Renmimbi [US$125.49 million]
of which 57%
was Biological Products), and
Novartis India Limited
based in India
(8.08 billion Indian Rupees [US$125.53 million]
of which 81%
During the year ended December of 2016, sales at
Indofarma (Persero) Tbk PT were 1.67 trillion Indonesian Rupiahs (US$125.77 million).
increase of 3.3%
versus 2015, when the company's sales were 1.62 trillion Indonesian Rupiahs.
This was the fourth straight year of sales growth at Indofarma (Persero) Tbk PT.